Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A

Published:2021 Issue:1 Volume:61 Page:35-41
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Kinoshita Tomohiro¹²,Watanabe Takashi³,Itoh Kuniaki⁴,Yoshimura Kenichi⁵,Tobinai Kensei³,Ogura Michinori²,Yamaguchi Motoko⁶,Kurosawa Mitsutoshi⁷,Imaizumi Yoshitaka⁸,Ota Shuichi⁹,Kaba Harumi¹⁰,Mukai Kiyoshi¹¹,Nakamura Shigeo¹²,Ohshima Koichi¹³,Hotta Tomomitsu¹⁴,Tsukasaki Kunihiro¹⁵,Nagai Hirokazu¹⁶,Shimoyama Masanori¹⁷

Affiliation:

1. Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan,

2. Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan,

3. Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,

4. Division of Oncology and Hematology, National Cancer Center Hospital East, Kashiwa, Japan,

5. Department of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan,

6. Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan,

7. Department of Hematology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan,

8. Nagasaki University Hospital, Nagasaki, Japan,

9. Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan,

10. Data Management Division, Clinical Research Support Office, National Cancer Center, Tokyo, Japan,

11. Pathology Division, National Cancer Center Research Institute, Tokyo, Japan,

12. Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan,

13. First Department of Pathology, Kurume University School of Medicine, Kurume, Japan,

14. Department of Hematology and Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan,

15. Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan,

16. Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan,

17. National Cancer Center Hospital, Tokyo, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/61/1/61_20062/_pdf

Reference26 articles.

1. 1 Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999; 17: 3835-3849.

2. 2 . The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000; 50: 696-702.

3. 3 Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol. 1998; 9: 717-720.

4. 4 Muto R, Miyoshi H, Sato K et al. Epidemiology and secular trends of malignant lymphoma in Japan: analysis of 9426 cases according to the World Health Organization classification. Cancer Med. 2018; 7: 5843-5858.

5. 5 A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood. 1997; 89: 3909-3918.